vs
CULP INC（CULP）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是CULP INC的1.3倍（$69.8M vs $53.2M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -8.1%，领先392.1%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -4.4%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -6.2%）
Culp Inc是全球领先的纺织品制造商，主营住宅及商用家具装饰面料、床垫面料产品，为家具生产商、床上用品供应商提供配套原材料，业务覆盖北美、亚洲、欧洲等主要市场。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
CULP vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.3倍
$53.2M
营收增速更快
RIGL
高出25.6%
-4.4%
净利率更高
RIGL
高出392.1%
-8.1%
两年增速更快
RIGL
近两年复合增速
-6.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $53.2M | $69.8M |
| 净利润 | $-4.3M | $268.1M |
| 毛利率 | 10.9% | 91.5% |
| 营业利润率 | -6.5% | 33.2% |
| 净利率 | -8.1% | 384.0% |
| 营收同比 | -4.4% | 21.2% |
| 净利润同比 | 23.7% | 1769.2% |
| 每股收益（稀释后） | $-0.34 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CULPRIGL
| Q4 25 | $53.2M | $69.8M | ||
| Q3 25 | $50.7M | $69.5M | ||
| Q2 25 | $48.8M | $101.7M | ||
| Q1 25 | $52.3M | $53.3M | ||
| Q4 24 | $55.7M | $57.6M | ||
| Q3 24 | $56.5M | $55.3M | ||
| Q2 24 | $49.5M | $36.8M | ||
| Q1 24 | $60.4M | $29.5M |
净利润CULPRIGL
| Q4 25 | $-4.3M | $268.1M | ||
| Q3 25 | $-231.0K | $27.9M | ||
| Q2 25 | $-2.1M | $59.6M | ||
| Q1 25 | $-4.1M | $11.4M | ||
| Q4 24 | $-5.6M | $14.3M | ||
| Q3 24 | $-7.3M | $12.4M | ||
| Q2 24 | $-4.9M | $-1.0M | ||
| Q1 24 | $-3.2M | $-8.2M |
毛利率CULPRIGL
| Q4 25 | 10.9% | 91.5% | ||
| Q3 25 | 14.3% | 93.2% | ||
| Q2 25 | 15.7% | 95.6% | ||
| Q1 25 | 12.1% | 91.7% | ||
| Q4 24 | 10.8% | 89.9% | ||
| Q3 24 | 9.0% | 85.5% | ||
| Q2 24 | 10.5% | 92.4% | ||
| Q1 24 | 12.7% | 93.1% |
营业利润率CULPRIGL
| Q4 25 | -6.5% | 33.2% | ||
| Q3 25 | 3.2% | 40.9% | ||
| Q2 25 | -4.6% | 60.1% | ||
| Q1 25 | -7.4% | 23.9% | ||
| Q4 24 | -9.7% | 28.9% | ||
| Q3 24 | -12.1% | 25.4% | ||
| Q2 24 | -8.6% | 1.2% | ||
| Q1 24 | -2.9% | -23.6% |
净利率CULPRIGL
| Q4 25 | -8.1% | 384.0% | ||
| Q3 25 | -0.5% | 40.2% | ||
| Q2 25 | -4.2% | 58.6% | ||
| Q1 25 | -7.9% | 21.5% | ||
| Q4 24 | -10.1% | 24.9% | ||
| Q3 24 | -12.8% | 22.5% | ||
| Q2 24 | -9.8% | -2.8% | ||
| Q1 24 | -5.3% | -27.9% |
每股收益（稀释后）CULPRIGL
| Q4 25 | $-0.34 | $14.11 | ||
| Q3 25 | $-0.02 | $1.46 | ||
| Q2 25 | $-0.17 | $3.28 | ||
| Q1 25 | $-0.33 | $0.63 | ||
| Q4 24 | $-0.45 | $0.82 | ||
| Q3 24 | $-0.58 | $0.70 | ||
| Q2 24 | $-0.39 | $-0.06 | ||
| Q1 24 | $-0.26 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $10.7M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $53.6M | $391.5M |
| 总资产 | $125.2M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资CULPRIGL
| Q4 25 | $10.7M | $155.0M | ||
| Q3 25 | $11.1M | $137.1M | ||
| Q2 25 | $5.6M | $108.4M | ||
| Q1 25 | $5.3M | $77.1M | ||
| Q4 24 | $10.5M | $77.3M | ||
| Q3 24 | $13.5M | $61.1M | ||
| Q2 24 | $10.0M | $49.1M | ||
| Q1 24 | $12.6M | $49.5M |
总债务CULPRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益CULPRIGL
| Q4 25 | $53.6M | $391.5M | ||
| Q3 25 | $57.6M | $117.6M | ||
| Q2 25 | $57.6M | $81.9M | ||
| Q1 25 | $59.6M | $18.6M | ||
| Q4 24 | $63.6M | $3.3M | ||
| Q3 24 | $69.1M | $-14.6M | ||
| Q2 24 | $76.1M | $-29.9M | ||
| Q1 24 | $80.8M | $-31.7M |
总资产CULPRIGL
| Q4 25 | $125.2M | $513.6M | ||
| Q3 25 | $126.4M | $242.5M | ||
| Q2 25 | $123.4M | $206.7M | ||
| Q1 25 | $127.6M | $176.0M | ||
| Q4 24 | $129.0M | $164.0M | ||
| Q3 24 | $129.1M | $139.4M | ||
| Q2 24 | $132.1M | $128.4M | ||
| Q1 24 | $142.0M | $126.5M |
负债/权益比CULPRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-471.0K | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $-510.0K | — |
| 自由现金流率自由现金流/营收 | -1.0% | — |
| 资本支出强度资本支出/营收 | 0.1% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $-17.8M | — |
8季度趋势，按日历期对齐
经营现金流CULPRIGL
| Q4 25 | $-471.0K | $22.0M | ||
| Q3 25 | $-695.0K | $24.0M | ||
| Q2 25 | $-8.2M | $30.5M | ||
| Q1 25 | $-6.8M | $-893.0K | ||
| Q4 24 | $-2.4M | $14.5M | ||
| Q3 24 | $-206.0K | $21.7M | ||
| Q2 24 | $-2.3M | $302.0K | ||
| Q1 24 | $-1.5M | $-5.0M |
自由现金流CULPRIGL
| Q4 25 | $-510.0K | — | ||
| Q3 25 | $-874.0K | — | ||
| Q2 25 | $-8.7M | — | ||
| Q1 25 | $-7.7M | — | ||
| Q4 24 | $-3.5M | — | ||
| Q3 24 | $-707.0K | — | ||
| Q2 24 | $-2.7M | — | ||
| Q1 24 | $-2.8M | — |
自由现金流率CULPRIGL
| Q4 25 | -1.0% | — | ||
| Q3 25 | -1.7% | — | ||
| Q2 25 | -17.9% | — | ||
| Q1 25 | -14.6% | — | ||
| Q4 24 | -6.3% | — | ||
| Q3 24 | -1.3% | — | ||
| Q2 24 | -5.5% | — | ||
| Q1 24 | -4.6% | — |
资本支出强度CULPRIGL
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.4% | — | ||
| Q2 25 | 1.0% | — | ||
| Q1 25 | 1.6% | — | ||
| Q4 24 | 1.9% | — | ||
| Q3 24 | 0.9% | — | ||
| Q2 24 | 0.9% | — | ||
| Q1 24 | 2.1% | — |
现金转化率CULPRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CULP
| Bedding Fabrics | $30.8M | 58% |
| Upholstery | $22.4M | 42% |
RIGL
暂无分部数据
